(Q40891443)

24 September 2017

1 reference

title

Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure (English)

1 reference

24 September 2017

1 reference

J Hoyer

1

1 reference

24 September 2017

K L Schulte

series ordinal

2

1 reference

24 September 2017

T Lenz

series ordinal

3

1 reference

24 September 2017

publication date

1 March 1993

1 reference

Clinical Pharmacokinetics

24 September 2017

published in

1 reference

24 September 2017

volume

24

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

230-254

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199324030-00005

24 September 2017

exact match

0 references

cites work

Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment

1 reference

12 December 2020

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

The pharmacokinetics of captopril and captopril disulfide conjugates in uraemic patients on maintenance dialysis: Comparison with patients with normal renal function

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (delapril) in patients with deteriorated kidney function and in normal control subjects

1 reference

12 December 2020

Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure

1 reference

12 December 2020

The clinical pharmacokinetics of quinapril

1 reference

12 December 2020

Safety issues during antihypertensive treatment with angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Elimination kinetics of captopril in patients with renal failure

1 reference

12 December 2020

Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors

1 reference

12 December 2020

Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease

1 reference

12 December 2020

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

12 December 2020

Disposition of captopril in normal subjects

1 reference

12 December 2020

The clinical role of angiotensin converting enzyme inhibitors in antihypertensive therapy in the 1990s.

1 reference

12 December 2020

In vitro biotransformations of [14C]captopril in the blood of rats, dogs and humans

1 reference

12 December 2020

Disposition of enalapril and enalaprilat in renal insufficiency

1 reference

12 December 2020

Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease

1 reference

12 December 2020

The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment

1 reference

12 December 2020

Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril.HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (alacepril) after oral dosing in fasting or fed states.

1 reference

12 December 2020

Blood concentration and urinary excretion of enalapril in patients with chronic renal failure.

1 reference

12 December 2020

Pharmacokinetics and acute effect on the renin-angiotensin system of delapril in patients with chronic renal failure.

1 reference

12 December 2020

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

1 reference

12 December 2020

Pharmacokinetics of newer drugs in patients with renal impairment (Part I).

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors and moderate hypertension

1 reference

12 December 2020

Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology

1 reference

12 December 2020

Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure

1 reference

12 December 2020

Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients

1 reference

12 December 2020

Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.

1 reference

12 December 2020

Captopril disulfide conjugates may act as prodrugs: Disposition of the disulfide dimer of captopril in the rat

1 reference

12 December 2020

Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders

1 reference

12 December 2020

Clinical Pharmacology of Cilazapril

1 reference

12 December 2020

Influence of renal function on the pharmacokinetics of ramipril (HOE 498)

1 reference

12 December 2020

The effect of renal function on enalapril kinetics

1 reference

12 December 2020

Enalapril maleate and a lysine analogue (MK-521): disposition in man

1 reference

12 December 2020

Disposition of fosinopril sodium in healthy subjects

1 reference

12 December 2020

Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

Angiotensin actions in the kidney: Renewed insight into the old hormone

1 reference

12 December 2020

Clinical pharmacokinetics of the newer ACE inhibitors. A review

1 reference

12 December 2020

The pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients with various degrees of renal function

1 reference

12 December 2020

Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis

1 reference

12 December 2020

Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.

1 reference

12 December 2020

Treatment of hypertension with lisinopril in end-stage renal failure

1 reference

12 December 2020

Arterial hypertension in chronic glomerulonephritis. An analysis of 310 cases.

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations

1 reference

12 December 2020

Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: findings of the Fosinopril Study Group II

1 reference

12 December 2020

Kinetic-dynamic relations and individual responses to enalapril

1 reference

12 December 2020

[Clinical pharmacology of enalapril in hypertension with chronic renal failure]

1 reference

12 December 2020

Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of captopril in patients undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of pentopril, a new angiotensin-converting-enzyme inhibitor in humans.

1 reference

12 December 2020

Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders

1 reference

12 December 2020

The clinical pharmacology of lisinopril

1 reference

12 December 2020

Effect of renal impairment on disposition of pentopril and its active metabolite

1 reference

12 December 2020

New angiotensin converting enzyme inhibitors. Their role in the management of hypertension

1 reference

12 December 2020

Pharmacokinetics of fosinopril in patients with various degrees of renal function

1 reference

12 December 2020

Pharmacokinetics of quinapril and its active metabolite quinaprilat during continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Steady-state kinetics of ramipril in renal failure

1 reference

12 December 2020

Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis

1 reference

12 December 2020

Renal insufficiency in treated essential hypertension

1 reference

12 December 2020

An overview of the clinical pharmacology of enalapril

1 reference

12 December 2020

Reduction of proteinuria by angiotensin converting enzyme inhibition

1 reference

12 December 2020

National High Blood Pressure Education Program Working Group report on hypertension and chronic renal failure

1 reference

12 December 2020

Captopril (SQ 14225) clearance during hemodialysis treatment.

1 reference

12 December 2020

Lisinopril pharmacokinetics in chronic renal failure

1 reference

12 December 2020

Perindopril. A review of its pharmacokinetics and clinical pharmacology

1 reference

12 December 2020

Captopril in hypertension; seven years later

1 reference

12 December 2020

Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension

1 reference

12 December 2020

The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure

1 reference

12 December 2020

Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man

1 reference

12 December 2020

Pharmacokinetics of cilazapril in patients with renal failure

1 reference

12 December 2020

Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal or impaired renal function

1 reference

12 December 2020

Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency.

1 reference

12 December 2020

Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity

1 reference

12 December 2020

Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders

1 reference

12 December 2020

Converting-enzyme inhibitors in the treatment of hypertension

1 reference

12 December 2020

The pharmacokinetics and bioavailability of cilazapril in normal man.

1 reference

12 December 2020

Pharmacokinetics of a single dose of ramipril in patients with renal dysfunction: comparison with essential hypertension.

1 reference

12 December 2020

Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency

1 reference

12 December 2020

Therapeutic benefit of converting-enzyme inhibition in progressive renal disease

1 reference

12 December 2020

Renal protective effects of angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study

1 reference

12 December 2020

Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure

1 reference

12 December 2020

Overview of quinapril, a new ACE inhibitor

1 reference

12 December 2020

Pharmacokinetics and Antihypertensive Effects of Lisinopril in Hypertensive Patients with Normal and Impaired Renal Function

1 reference

12 December 2020

Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients

1 reference

12 December 2020

Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency

1 reference

12 December 2020

Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension

1 reference

12 December 2020

Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics of enalapril in normal subjects and patients with renal impairment

1 reference

12 December 2020

Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

Pharmacokinetics of newer drugs in patients with renal impairment (Part II).

1 reference

12 December 2020

Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy

1 reference

12 December 2020

Progression of renal insufficiency: role of blood pressure

1 reference

12 December 2020

Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy

1 reference

12 December 2020

Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction

1 reference

12 December 2020

Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis

1 reference

12 December 2020

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

1 reference

12 December 2020

Metabolites of antihypertensive drugs. An updated review of their clinical pharmacokinetic and therapeutic implications

1 reference

12 December 2020

Lisinopril in hypertensive patients with and without renal failure.

1 reference

12 December 2020

10.2165/00003088-199324030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1029240829

0 references

1 reference